Published on 9 Dec 2022 on The Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
Baudax (NASDAQ: BXRX) sold 1.04 million shares of common stock along with warrants to purchase two...
NASDAQ.BXRX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free